Sign in
CompletedNo phase

ACE and HLA Genotypes Predict Severity and Disease Progression in Danish Sarcoid Patients

Key facts

Who runs it
University of Aarhus
Where
Denmark1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
150 people enrolled
Started
1 Dec 2019
Ended
30 Nov 2023
Type of study
Observational
Record updated
25 January 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Diagnosis of sarcoidosis
  • Signed informed consent

Who cannot take part

  • Inability or unwillingness to adhere to the study
  • Inability to give informed consent

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Sarcoidosis is a multisystem granulomatous disease of unknown cause histologically characterized by noncaseating granulomas. Genetic factors affect disease course, which is highly variable and difficult to predict.

Read full original descriptionShow less

This study aims to evaluate the predictive value of ACE and HLA genotypes on disease severity and progression in Danish patients with sarcoidosis.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
25 January 2024